688505.SH
复旦张江
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 8.38
−3.01%Margins
Gross margin
90.0%
EBITDA margin
-12.6%
EBIT margin
-23.0%
Net margin
-23.3%
FCF margin
14.5%
-7.2%
Return on equity
-6.5%
Return on assets
-7.1%
Return on invested capital
0.28x
Asset turnover
CNY 127.9M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026